Ocular Manifestations of Inflammatory Bowel Disease

Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis in the literature (0.5% -3%), study on a large sample to assess their prevalence in patients with IBD at the Nancy CHRU and describe all the ocular manifestations that can be found.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammatory Bowel Diseases Digestive System Diseases Eye Diseases Gastroenteritis Gastrointestinal Diseases Intestinal Diseases Ophthalmopathy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients followed at Nancy University Hospital for IBD and having consulted in the ophthalmology department

Exclusion criteria

Minor patients
patients without IBD
patients for whom there is no ophthalmology consultation

Treatment and study plan

reason for consultation

Other

search in medical files for reasons for ophthalmology consultation, functional signs, clinical signs, treatment, characteristics of IBD

Primary outcomes

frequency

Time frame: baseline

frequency of ocular manifestations in inflammatory bowel disease

Secondary outcomes

Number

Time frame: baseline

Number of uveitis, scleritis and episcleritis; prevalence calculation

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Official study title

Ocular Manifestations of Chronic Inflammatory Bowel Disease (IBD): Retrospective Study in the Hepato-gastroenterology Department of the Nancy CHRU

Important dates

Study start: 2013
Primary completion: 2020
Study completion: 2020
First posted: Feb 25, 2021
Registry last updated: Feb 25, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed